Skip to main content
OpenTrials
Completed

NCT Number: NCT03429673

A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-small Cell Lung Cancer Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

China People's Liberation Army Hospital, Beijing, Beijing Municipality, China

Loading trial locations.

About this study

The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 to 2017 who received lobectomy or segment/wedge dissection were included and the study data on patient demographic/tumor biological characteristics, and clinical treatments were retrospectively collected to evaluate effectiveness and safety of the surgeries.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who received surgeries from 2014 to 2017;
  • Patients who received lobectomy or segment/wedge dissection;
  • Pathologically diagnosed patients with non-small cell lung cancer;
  • Patients with age >=65 years old.

Exclusion criteria

  • Patients who received neoadjuvant therapy prior to surgery.

Treatment and study plan

Surgeries

Procedure

Lobectomy or segment/wedge dissection

Primary outcomes

  1. Overall survival

    Time frame: 2015-2017

    Overall survival

Other outcomes

  1. Overall survivals in the subgroups

    Time frame: 2015-2017

    Overall survivals in the subgroups categorised by age, tumor size, and clinical/pathological staging

  2. Impact factors of overall survival

    Time frame: 2015-2017

    Impact factors of overall survival as measured by patient demographic/tumor biological characteristics

  3. Death rate within 30/90 days after surgeries

    Time frame: 2015-2017

    Death rate within 30/90 days after surgeries

  4. Incidence of perioperative complications

    Time frame: 2015-2017

    Incidence of perioperative complications

Sponsors and collaborators

Lead sponsor

China-Japan Friendship Hospital

Other

Collaborators

  • LinkDoc Technology (Beijing) Co. Ltd.

Registry information

Official study title

A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Feb 12, 2018
Registry last updated
May 21, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.